Enhanced Games bets on doping controversy to launch new business model

Las Vegas became the launchpad for a sports project that treated drug-fueled performance less like a scandal than a market. The Enhanced Games, founded in 2023 by Australian entrepreneur Aron D’Souza, said it would stage its inaugural competition over Memorial Day Weekend 2026 with a $25 million purse and a $1 million prize tied to swimmer Kristian Gkolomeev’s world-record performance.

That business model has been built around a blunt premise: if elite athletes already chase every legal edge, then performance-enhancing drugs, peptides and medicalized optimization can be packaged, sold and normalized. Enhanced said its athletes were supervised through an independent Medical Commission and that it was building a broader consumer platform around “performance medicine” and supplements. On March 18, 2026, the company said that personalized performance medicine and supplement platform was live, a sign that the competition was never meant to stand alone as a sporting spectacle.

The backlash came fast and from the sport’s governing institutions. The World Anti-Doping Agency condemned the Enhanced Games on May 22, 2025 as a “dangerous and irresponsible” concept, and WADA’s Athlete Council strongly opposed it. Athlete representatives from the International Olympic Committee also denounced the project, calling it a betrayal of what they stand for. In a sport system built on drug testing, therapeutic-use rules and public trust in fair competition, the Enhanced model pushed directly against the guardrails that protect athletes, especially younger competitors who absorb the message that risk is just another cost of doing business.

The fight also exposed the larger Silicon Valley ideology behind the project. Peptides have become a trendy gray-market tool in tech circles, sold and discussed as part of biohacking and longevity culture for weight loss, muscle gain, recovery and anti-aging. That movement has been framed by some as “healthspan” innovation, but critics warn that the products are often unproven and can carry safety risks. Enhanced has tried to ride that same current, turning a controversial sports event into a consumer channel for self-optimization.

Enhanced’s legal fight added another layer. WADA said a federal court dismissed the company’s antitrust claim against WADA, World Aquatics and USA Swimming in December 2025. By then, the company had already made clear that it was not just selling a meet in Las Vegas; it was selling a worldview in which human bodies, medical risk and investor money could be fused into one new, highly monetized product.